Middletown, DE -- (SBWIRE) -- 10/03/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: GT Advanced Technologies Inc(NASDAQ:GTAT), Windstream Holdings Inc(NASDAQ:WIN), DARA Biosciences Inc(NASDAQ:DARA), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA)
GT Advanced Technologies Inc(NASDAQ:GTAT) gained volume of 4.46 million shares and the average volume of the stock remained 4.32 million shares. The 52 week range of the stock remained $2.61 - $8.99 and the day range was $8.63 - $8.99.The stock opened the session at $8.69, and closed the session at $8.80. The stock showed a positive performance of +0.69% in previous trading session. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide. The company operates through three segments: Polysilicon; Photovoltaic (PV); and Sapphire. The Polysilicon segment offers silicon deposition reactors; equipment, technology.
For How Long GTAT’s Gloss will Attract Investors? Find out via this report
In previous session, Windstream Holdings Inc(NASDAQ:WIN) traded 4.40 million shares and the average volume of the stock remained 4.76 million shares. The 52 week range of the stock remained $7.50 - $10.27. The stock was a bear and dropped -0.24%, while its closing price stayed at $8.17. The market capitalization of the stock remained 4.84 billion. The half-yearly trend of the stock remained negative -0.61%. Windstream Holdings, Inc. provides communications and technology solutions in the United States. The company offers managed services and cloud computing services to businesses, as well as broadband, voice, and video services to consumers primarily in rural markets.
Has WIN Found The Bottom And Ready To Gain Momentum? Find Out Here
DARA Biosciences Inc(NASDAQ:DARA) volume of the stock was 4.21 million shares in the most recent session and the average volume remained 162,782.00 shares. The stock boosted +41.24% and finished the prior session at the closing price of $0.695. The stock traded 4.21 million shares in its previous trading session and its average volume remained 162,782.00 shares. DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. It offers Soltamox for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina.
Will DARA Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) traded with volume of 4.19 million shares and the average volume of the stock remained 5.11 million shares. The stock decreased -2.15% and finished the trading at $5.00. The market capitalization of the stock remained 1.09 billion. The beta of the stock remained 0.05. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States. The company has a marketing and supply agreement with Ildong Pharmaceutical Co., Ltd. for the commercialization of BELVIQ in South Korea.
Will ARNA Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)